SWISS RE LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.02 EUR | +1.04% |
|
-.--% | -.--% |
| 05-03 | SWISS REINSURANCE COMPANY : Gets a Neutral rating from Barclays | ZD |
| 04-22 | Swiss Re to Roll Out AI-Powered Insurance Underwriting Assistant | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.73 for the current period. Therefore, the company is undervalued.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Reinsurance
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -.--% | 33.96B | - | ||
| +8.73% | 6.43B | - | - | |
| +19.65% | 6.24B | B | ||
| +3.77% | 4.53B | - | B | |
| +13.99% | 868M | C- | ||
| +23.21% | 701M | - | - | |
| +10.00% | 507M | - | - | |
| +100.82% | 410M | B- | ||
| +7.11% | 158M | - | - | |
| +9.84% | 152M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SREN Stock
- SR9 Stock
- Ratings Swiss Re Ltd
